Transforming synthetic biology with precise, cost-effective gene libraries.
SynPlexity enables researchers to scale biology with multiplexed DNA libraries — delivering more variants, faster discovery, and lower cost using proprietary DropSynth microreactor technology. The platform serves protein engineering, drug discovery, and functional genomics workflows, providing gene libraries up to 25,000+ fragments with in-house NGS quality control.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountNo funding data available yet.
Know something? Help us improve our data.
Create a free account to see which investors have funded this company.
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
Anthropic is an AI research company that builds reliable, interpretable, and steerable AI systems.
xAI is an AI platform for accelerating human scientific discovery.
Waymo is an autonomous driving technology company with a mission to make it safe and easy for peo...
